Serum aldosterone in right ventricular failure versus left ventricular failure before and after mineralocorticoid receptor antagonists: case-control clinical trial.
Noor Eldeen A M El-HefnyHanan Sharaf El-Deen MohammedReham I El-MahdySalma Hamdy M HaridiAbir S MohamedPublished in: Acta cardiologica (2023)
Aldosterone may have pathogenic role in HF. Measuring and follow-up of aldosterone levels should be considered in HF patients. MRA treatment gives a significant improvement in right side HF group.
Keyphrases
- clinical trial
- left ventricular
- case control
- angiotensin ii
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- acute heart failure
- heart failure
- prognostic factors
- acute myocardial infarction
- aortic stenosis
- magnetic resonance imaging
- hypertrophic cardiomyopathy
- patient reported outcomes
- magnetic resonance
- open label
- acute coronary syndrome
- percutaneous coronary intervention
- double blind
- patient reported